Century Therapeutics, Inc. (IPSC) Depreciation USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Century Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2024.
  • Century Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $3.23 M, a 10.9% increase year-over-year.
  • Century Therapeutics, Inc. Depreciation for the twelve months ending March 31, 2024 was $13.4 M, a 31.2% increase year-over-year.
  • Century Therapeutics, Inc. annual Depreciation for 2023 was $13 M, a 54.6% increase from 2022.
  • Century Therapeutics, Inc. annual Depreciation for 2022 was $8.44 M, a 125% increase from 2021.
  • Century Therapeutics, Inc. annual Depreciation for 2021 was $3.75 M, a 167% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $13.4 M $3.23 M +$318 K +10.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $13 M $3.55 M +$714 K +25.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $12.3 M $3.35 M +$576 K +20.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $11.8 M $3.23 M +$1.57 M +93.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $10.2 M $2.91 M +$1.75 M +151% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $8.44 M $2.84 M +$1.79 M +170% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $6.65 M $2.77 M +$1.73 M +166% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $4.92 M $1.67 M +$733 K +78.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $4.19 M $1.16 M +$442 K +61.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3.75 M $1.05 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $1.04 M +$634 K +155% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $935 K +$653 K +232% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $718 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 $410 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $282 K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.